Combination of Tagraxofusp and Azacitidine Is an Effective Option for Relapsed Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem-Cell Transplantation期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Combination of Tagraxofusp and Azacitidine Is an Effective Option for Relapsed Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem-Cell Transplantation

Authors:	Song-Yau Wang Katrin Thomassen Lars Kurch Sabine Opitz Georg-Nikolaus Franke Enrica Bach Uwe Platzbecker Sabine Kayser

Affiliation:	1. Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Kansas City, KS;2. Department of Internal Medicine, The University of Kansas Medical Center, Kansas City, KS;3. Division of Gastroenterology and Hepatology, University of Toledo, Toledo, OH, USA;4. Department of Internal Medicine, University of Toledo, Toledo, OH, USA;5. Department of Internal Medicine, Marshall University, Huntington, WV;6. Division of Hematological Malignancies, University of Utah, Salt Lake City, UT;7. Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Kansas City, KS

Abstract:

Keywords:	Allogeneic hematopoietic stem cell transplantation Azacitidine Blastic plasmacytoid dendritic cell neoplasm Tagraxofusp Treatment
本文献已被 ScienceDirect 等数据库收录！